Inflow

Emerging

London ADHD management app with CBT and coaching for adults managing ADHD without relying solely on medication; $16.7M Octopus Ventures Series A with 100K+ downloads competing with Done and Cerebral.

Updated March 2026

Company Overview

About Inflow

Inflow is a London-based digital health company providing a science-based self-management app for adults with ADHD — backed with $16.7 million raised including an $11 million Series A led by Octopus Ventures in 2023 — delivering cognitive behavioral therapy (CBT), psychoeducation, ADHD coaching, and evidence-based habit management tools through a mobile app that helps adults understand and manage their ADHD without relying exclusively on medication. Founded in 2020, Inflow acquired Lina Health in 2022 to expand telehealth capabilities and has achieved 100,000+ downloads, serving adults who are newly diagnosed, managing ADHD alongside medication, or seeking non-pharmacological coping strategies.

Business Model & Competitive Advantage

Inflow's therapeutic content library covers the specific challenges adults with ADHD face: executive function deficits (procrastination, task initiation, time management), emotional dysregulation, rejection sensitive dysphoria (RSD), and working memory limitations — each addressed through module-based CBT exercises, psychoeducation, and practical tools. The structured program approach (90+ days of evidence-based content) distinguishes Inflow from generic meditation apps that provide insufficient ADHD-specific structure. Community features (peer support groups within the app) address the social isolation that many adults with ADHD experience when traditional productivity and time management approaches consistently fail. The Lina Health acquisition added licensed therapist telehealth consultations for users who need clinical support beyond self-help.

Competitive Landscape 2025–2026

In 2025, Inflow competes in the digital mental health and ADHD management market with Done (ADHD telehealth, online diagnosis and prescriptions, $30M raised), Cerebral (mental health platform, $300M raised), and Headspace (meditation and mental health, $215M raised) for adult ADHD digital health spending. ADHD diagnosis rates have grown significantly among adults (estimated 8 million+ undiagnosed adults in the US) as awareness increased and telehealth diagnosis became more accessible. The controlled substance prescription challenges for ADHD medication (amphetamine shortage, stimulant prescribing restrictions) increase demand for behavioral and CBT-based ADHD management tools. Octopus Ventures' lead reflects UK venture investment in digital health. The 2025 strategy focuses on Inflow's employer benefit channel (ADHD management as a workplace wellness benefit), expanding the coaching subscription, and building clinical partnerships for the NHS digital mental health agenda.

Revenue
$16.7M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Inflow is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

Yoneda Labs

Healthcare
HealthtechB2bNorth America

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit

Decoda Health

Healthcare
HealthtechAi PoweredAutomationNorth America

Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap

Fortuna Health

Healthcare
HealthtechB2bAi PoweredAutomationNorth America

Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

AbbVie

Healthcare
AnalyticsB2bEnterpriseGlobalHealthtechPublic

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp

Compare Inflow with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Inflow

Claim This Profile

Are you from Inflow? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Inflow Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Inflow vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →